CADL- Candel Therapeutics, Inc.

Name: Candel Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Candel Therapeutics, Inc. (CADL) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CADL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Manning Paul B	2.21M	$18.48M	-
CEO	Tak Paul Peter	629.0K	$5.25M	-
CFO	Schoch Charles	232.0K	$1.94M	-
Other	Barone Francesca	232.0K	$1.94M	-
Other	Tyagarajan Seshu	154.0K	$1.29M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 29, 2024	Nichols William Garrett66	Chief Medical Officer	Sell	13,935	$4.56	$63,482.29	-12.2%	+82.8%	+1.4%
Nov 29, 2024	Barone Francesca58	Chief Scientific Officer	Sell	22,081	$4.56	$100,592.20	-13.8%	+82.8%	+1.4%
Oct 15, 2024	Aguilar-Cordova Estuardo49	10% Owner	Sell	40,412	$6.03	$243,834.36	-1.4%	+30.6%	+0.4%
Oct 3, 2024	Aguilar-Cordova Estuardo49	10% Owner	Sell	35,002	$6.93	$242,641.51	-1.2%	+34.0%	-17.1%
Jul 17, 2024	Tyagarajan Seshu53	Chief Technology Officer	Sell	14,851	$6.47	$96,124.58	-9.2%	-9.4%	+5.3%
Jul 17, 2024	Tak Paul Peter58	Chief Executive Officer	Sell	22,528	$6.47	$145,814.73	-6.4%	-9.4%	+5.3%
Jul 17, 2024	Schoch Charles65	See Remarks	Sell	9,884	$6.47	$63,975.18	-13.7%	-9.4%	+5.3%
Jul 17, 2024	Nichols William Garrett66	Chief Medical Officer	Sell	10,875	$6.47	$70,389.53	-8.7%	-9.4%	+5.3%
Jul 17, 2024	Barone Francesca58	Chief Scientific Officer	Sell	14,051	$6.47	$90,946.50	-8.1%	-9.4%	+5.3%
Jul 11, 2024	Tak Paul Peter58	Chief Executive Officer	Sell	20,293	$5.97	$121,218.21	-5.4%	+1.4%	-1.7%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC